$180,000,000
The Fund seeks significant capital appreciation through the acquisition of privately secured and negotiated early-stage equity investments in healthcare related companies. The General Partner is a newly-formed venture capital partnership that will focus on private investments in the global healthcare sector with a significant China advantage.